• 11/30/2024

Novo Nordisk Confident as Ozempic, Wegovy Demand Continues

Wall Street Journal

The Danish pharmaceutical giant raised its full-year guidance to reflect better pricing in the U.S. and as global demand for its weight-loss and diabetes drugs continued to outstrip supply.

https://www.wsj.com/articles/novo-nordisk-lifts-guidance-as-blockbuster-drug-demand-shows-no-signs-of-abating-5d72591f